Pathak V, Flatt PR, Irwin N (2018) Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes
Alternate injection sites include the outer thigh or upper arm fatty tissue if rotating sites to prevent lipohypertrophy (tissue buildup from repeated injections)
Interestingly, the mesenchymal shift by Day 45 suggests greater cellular complexity at later stages, potentially facilitating iHLO use in modeling liver pathologies such as fibrosis, cirrhosis, and liver remodeling, as indicated by increased expression of hepatic stellate cell markers such as DES and VIM 33,34
The platform is designed for self-managers
With increasing administration, reports of intoxications are more frequently reported
This, in turn, helps you eat less and make healthier food choices